The combination of CXCL12 and CXCR4 can activate signaling pathways such as MAPK/ERK, PI3K/Akt/NF-κB, and c-Jun N-terminal kinase and regulate tumor progression [48,49]. This evidence concerns the gene AKT1 and neoplasm.